Stock Information
IRadimed Corp (IRMD)
Ticker Symbol: IRMD
Exchange: NASDAQ
Sector: Health Care
Market Cap: $1,224.16 mil
Piotroski score: 5
PE Ratio: 49.466
EPS (TTM): 1.7487
Revenue (TTM): $6.50 M
Dividend Yield: 0.85807050092764%
ROE: 23.83%
Latest News
-
IRADIMED CORPORATION (IRMD) Q1 2026 Earnings Call Transcript
Fri, May 1, 2026 6:11 PM
-
IRADIMED (NASDAQ:IRMD) Beats Q1 Estimates, But Cautious Q2 Guidance Tempers Outlook
Fri, May 1, 2026 1:20 PM
-
Transcript : IRADIMED CORPORATION, Q1 2026 Earnings Call, May 01, 2026
Fri, May 1, 2026 12:20 PM
-
IRADIMED CORPORATION Reports Earnings Results for the First Quarter Ended March 31, 2026
Fri, May 1, 2026 10:50 AM
-
IRadimed: Q1 Earnings Snapshot
Fri, May 1, 2026 8:40 AM
-
iRadimed Affirms FY2026 GAAP EPS Guidance of $1.90-$2.05 vs $1.91 Est
Fri, May 1, 2026 8:35 AM
-
iRadimed Affirms FY2026 Adj EPS Guidance of $2.06-$2.21 vs $2.08 Est; Affirms FY2026 Sales Guidance of $91.000M-$96.000M vs $92.346M Est
Fri, May 1, 2026 8:34 AM
-
iRadimed Sees Q2 GAAP EPS $0.40-$0.44 vs $0.42 Est
Fri, May 1, 2026 8:33 AM
-
iRadimed Sees Q2 Adj EPS $0.44-$0.48 vs $0.47 Est; Sees Sales $20.000M-$21.000M vs $21.134M Est
Fri, May 1, 2026 8:33 AM
-
iRadimed Q1 Adj. EPS $0.49 Beats $0.45 Estimate, Sales $21.979M Beat $21.315M Estimate
Fri, May 1, 2026 8:31 AM
Key Financials
Financial data not available
